Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized, Masked, Controlled Trial To Evaluate The Safety And Effectiveness Of The TearCare® System In The Treatment Of The Signs And Symptoms Of Dry Eye Disease (SAHARA)

NCT04795752 is registered in ClinicalTrials.gov with Sight Sciences, Inc. as lead sponsor.

NCT NCT04795752
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04795752 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized, Masked, Controlled Trial To Evaluate The Safety And Effectiveness Of The TearCare® System In The Treatment Of The Signs And Symptoms Of Dry Eye Disease (SAHARA)
Lead sponsor
Sight Sciences, Inc.
Phase
Not applicable
Overall status
Completed
Start date
April 28, 2021
Completion date
September 23, 2024
Enrollment
345 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye, meibomian gland dysfunction